The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Nicotinic Immune Modulation in the Presence of HIV-1 Infection (R01)
The FOA encourages the submission of research project applications to determine nicotine’s modulatory effects on peripheral and central immune system functions in the presence of HIV-1 infection. Specifically, NIDA is particularly interested in projects exploring the ability of nicotine to produce anti-inflammatory and protective effects, and the translational potential of the new knowledge in attenuating HIV-induced pathologies and HIV-associated CNS complications such as neurological/cognitive disorders.
- Letter of Intent Due Date(s): 30 days prior to the application due date
- Application Due Date(s): January 17, 2017
- AIDS Application Due Date(s): January 17, 2017
RFA-DA-17-020 Expiration Date January 18, 2017